NextCure, Inc. (NXTC) Misses Q3 EPS by 277c

NextCure, Inc. (NASDAQ: NXTC) reported Q3 EPS of ($3.22), $2.77 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on NextCure, Inc. (NXTC) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Hunterbrook bullish on Modine Manufacturing (MOD)
• Micron Technology (MU) call put ratio 1.3 calls to 1 put as share price down 1%